Terms: = Gastric cancer AND PPFIBP1, L2, 8496, ENSG00000110841, hSGT2, hSgt2p AND Prognosis
10 results:
1. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
[TBL] [Abstract] [Full Text] [Related]
2. A Signature Based on Costimulatory Molecules for the Assessment of prognosis and Immune Characteristics in Patients With Stomach Adenocarcinoma.
Chen B; Yao Y; Mao D; Li C; Wang X; Sheng S; Zhang L; Wang X; Chen S; Xu W; Deng J; Sun C; Zhou Q; Lowe S; Bentley R; Shao W; Li H
Front Immunol; 2022; 13():928742. PubMed ID: 35935979
[TBL] [Abstract] [Full Text] [Related]
3. Epstein-Barr virus-associated gastric cancer: A distinct subtype.
Yang J; Liu Z; Zeng B; Hu G; Gan R
Cancer Lett; 2020 Dec; 495():191-199. PubMed ID: 32979463
[TBL] [Abstract] [Full Text] [Related]
4. Profiles of PD-1, PD-L1, PD-L2 in gastric cancer and Their Relation with Mutation, Immune Infiltration, and Survival.
Liu J; Li H; Sun L; Yuan Y; Xing C
Biomed Res Int; 2020; 2020():2496582. PubMed ID: 32596285
[TBL] [Abstract] [Full Text] [Related]
5. From Tumor Immunology to Immunotherapy in gastric and Esophageal cancer.
Vrána D; Matzenauer M; Neoral Č; Aujeský R; Vrba R; Melichar B; Rušarová N; Bartoušková M; Jankowski J
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30577521
[TBL] [Abstract] [Full Text] [Related]
6. Polymorphism of the programmed death-ligand 1 gene is associated with its protein expression and prognosis in gastric cancer.
Wu Y; Zhao T; Jia Z; Cao D; Cao X; Pan Y; Zhao D; Zhang B; Jiang J
J Gastroenterol Hepatol; 2019 Jul; 34(7):1201-1207. PubMed ID: 30353572
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial.
Touchefeu Y; Guimbaud R; Louvet C; Dahan L; Samalin E; Barbier E; Le Malicot K; Cohen R; Gornet JM; Aparicio T; Nguyen S; Azzedine A; Etienne PL; Phelip JM; Hammel P; Chapelle N; Sefrioui D; Mineur L; Lepage C; Bouche O
Gastric Cancer; 2019 May; 22(3):577-586. PubMed ID: 30311042
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.
Gao Y; Li S; Xu D; Chen S; Cai Y; Jiang W; Zhang X; Sun J; Wang K; Chang B; Wang F; Hong M
Chin J Cancer; 2017 Jul; 36(1):61. PubMed ID: 28754154
[TBL] [Abstract] [Full Text] [Related]
9. Update on Epstein-Barr virus and gastric cancer (review).
Shinozaki-Ushiku A; Kunita A; Fukayama M
Int J Oncol; 2015 Apr; 46(4):1421-34. PubMed ID: 25633561
[TBL] [Abstract] [Full Text] [Related]
10. Surgical management of gastric stump cancer: a report of 37 cases.
Chen L; Tian H; Chen J; He ZG; Tao SF; Lokesh G; Peng SY
J Zhejiang Univ Sci B; 2005 Jan; 6(1):38-42. PubMed ID: 15593390
[TBL] [Abstract] [Full Text] [Related]
